MARKET

CSBR

CSBR

Champions Oncolo
NASDAQ
4.240
-0.060
-1.40%
Closed 16:00 02/03 EST
OPEN
4.329
PREV CLOSE
4.300
HIGH
4.340
LOW
4.240
VOLUME
4.30K
TURNOVER
9.26K
52 WEEK HIGH
9.88
52 WEEK LOW
3.750
MARKET CAP
57.49M
P/E (TTM)
1060.00
1D
5D
1M
3M
1Y
5Y
Champions Oncology Trades At A Sufficient Discount To R&D Capacity
Seeking Alpha · 01/29 05:37
Champions Oncology's Return On Capital Employed Insights
Benzinga · 12/30/2022 14:46
Analyzing Champions Oncology's Short Interest
Benzinga · 12/15/2022 18:14
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga · 12/15/2022 17:32
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga · 12/14/2022 21:31
BRIEF-Champions Oncology Says Total Revenue For Q2 Of Fiscal 2023, Was A Record $14.3 Million, An Increase Of 21.2%
Reuters · 12/13/2022 21:16
Champions Oncology Q2 EPS $0.01 Down From $0.03 YoY, Sales $14.30M Up From $11.79M YoY
Benzinga · 12/13/2022 21:02
Champions Oncology Reports Record Quarterly Revenue of $14.3 Million
Champions Oncology, Inc. (Nasdaq:CSBR), a leading global technology-enabled biotech that is transforming drug discovery through innovative AI-driven pharmaco-pheno-multiomic integration, today announced its financial results for its second quarter of fisca...
ACCESSWIRE · 12/13/2022 21:00
More
About CSBR
Champions Oncology, Inc. is a technology-enabled research organization engaged in creating transformative technology solutions to be utilized in drug discovery and development. The Company's research center operates in both regulatory and non-regulatory environments and consists of a set of computational and experimental research platforms. The Company’s TumorGraft Technology Platform (The Platform) provides select services to pharmaceutical and biotechnology companies. Its software as-a service business is centered around its software platform and data tool, Lumin Bioinformatics (Lumin), which contains comprehensive information derived from its research services and clinical studies. Its drug discovery and development business leverages the computational and experimental capabilities within its platforms. Its discovery strategy utilizes its datacenter, coupled with artificial intelligence and other advanced computational analytics, to identify therapeutic targets.

Webull offers kinds of Champions Oncology Inc stock information, including NASDAQ:CSBR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CSBR stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading CSBR stock methods without spending real money on the virtual paper trading platform.